Distortion-product otoacoustic emissions ͑DPOAEs͒ were weak or absent in about one-third of sheep ͑Ovis aries͒ of both sexes tested for otoacoustic emissions ͑OAEs͒ even though their click-evoked OAEs ͑CEOAEs͒ seemingly were typical of other sheep of the same sex. Various pieces of evidence suggest that the absence of measurable DPOAEs was unlikely to be attributable to anesthetic effects, a poorly located probe tip, a pressure differential between middle and outer ears, season of the year, body position during testing, temperature effects, or previous medical history. Sheep apparently can exhibit a marked dissociation between DPOAEs and CEOAEs. In those sheep having measurable DPOAEs, the DPOAEs were stronger in males than in females, which is the opposite direction of effect from the CEOAEs measured in these same sheep and in humans. In female sheep exposed to higher-than-normal levels of androgens during gestation, the measurable DPOAEs were stronger than in untreated females. Although this also was the opposite direction of effect from expected, it still was a shift in the male direction, in accord with past findings about the masculinizing effects of androgens on OAEs. In sheep, androgen exposure appears to have different effects on the mechanisms underlying DPOAEs from those underlying CEOAEs.
I. INTRODUCTION
Current thinking is that the different forms of otoacoustic emissions ͑OAEs͒ originate from somewhat different underlying mechanisms. Shera and Guinan ͑1999͒ argued that spontaneous OAEs ͑SOAEs͒ and click-evoked OAEs ͑CEOAEs͒ originate primarily from a linear, reflection-based mechanism whereas distortion-product OAEs ͑DPOAEs͒ depend on both the reflection-based mechanism and a nonlinear distortion mechanism. A number of lines of evidence led Shera and Guinan ͑1999͒ to this distinction; among them was the fact that some agents or manipulations that affect the strength of CEOAEs have either less effect on or a welldelayed effect on DPOAEs. For example, the administration of aspirin or quinine sulfate to humans rapidly diminished the strength of SOAEs and CEOAEs, but DPOAEs were diminished less, and more slowly ͑e.g., Wier et al., 1988; McFadden and Pasanen, 1994 ; also see Whitehead et al., 1996͒. In the few studies where both CEOAEs and DPOAEs have been measured in the same individuals ͑Smurzynski and Kim, 1992; Moulin et al., 1993; Gorga et al., 1993͒ , the correlations between the two measures have been lower than the correlations typically seen between CEOAEs and SOAEs ͑e.g., McFadden et al., 2008a͒ . These various partial dissociations are understandable if the crucial underlying mechanisms are different for the different forms of OAE ͑Shera and Guinan, 1999͒. Human DPOAEs also exhibit a considerably smaller sex difference from those exhibited by CEOAEs and SOAEs ͑reviewed by McFadden et al., 2008a͒. Recently, while collecting OAE data on a sample of sheep, we encountered a number of animals having normalappearing CEOAEs but only very weak or absent DPOAEs. This was not universal for the species, for either sex, nor for any specific treatment group ͑some animals had been given androgens or estrogens prenatally or postnatally͒. Indeed, many sheep of both sexes exhibited quite strong DPOAEs along with strong CEOAEs. Below we discuss a number of possible technical and procedural explanations for this dissociation, but none was adequate to explain our outcomes. Accordingly, we believe that these are true instances of CEOAEs existing in ears lacking DPOAEs, which is logically possible if the mechanisms underlying the two types of OAE are different ͑Shera and Guinan, 1999͒. The CEOAE data from sheep already have been reported ͑McFadden et al., 2008b͒ ; the DPOAE data are reported separately here because of their significance for research on underlying mechanisms. The implication is that the processes primarily responsible for producing DPOAEs can be weak without preventing that ear from producing CEOAEs.
II. METHODS
Only a brief summary of the subjects and procedures will be presented here; additional details can be found in McFadden et al. ͑2008b͒ . All experimental procedures were performed in accordance with NIH guidelines and were approved by the University Committees on the Use and Care of Animals at both UM and UT. OAE measurements were obtained during three multiday visits of the UT team to Ann Arbor: in mid-November and mid-December 2006 and in mid-May 2007. The UM team created the various groups of treated animals to test an array of ideas about endocrine function and sex-typical behavior in sheep; they generously agreed to add the OAE measurements to their protocol long after the original planning and onset of their primary studies. The timing of the measurement sessions for OAEs was dictated by the schedule for the original projects.
A. Subjects
The sheep tested ͑Ovis aries͒ were of the Suffolk variety. At the time of OAE testing, the ages were approximately 20-26 months and approximately 8 -14 months for the females and males, respectively. Because puberty begins at about 6 months for females and at about 2 months for males, all of the sheep tested can be considered young adults ͑Kosut et al., 1997͒. The nominal lifespan of sheep is 8 -13 years.
The mothers of some of the sheep tested had been administered various hormones during their pregnancy. As a consequence, some of the sheep tested had been exposed to higher-than-normal levels of testosterone, dihydrotestosterone ͑DHT͒, or estradiol during prenatal development. The duration of gestation in sheep is about 147 days. The drug administrations occurred regularly beginning on day 30 of gestation and ending on day 90. The surge in androgen production that occurs normally in developing male sheep fetuses also begins about day 30 and lasts through about day 90 of gestation. Some sheep were gonadectomized ͑GDX͒ soon after birth, including sheep both treated and not treated with hormones prenatally. Thus, there were males and females that were untreated/intact, untreated/GDX, testosterone-treated/GDX, etc. Because essentially all of the non-GDX males had been vasectomized early in life, here we will denote the untreated/intact males as untreated/VX.
B. Procedure
The sheep lived outdoors in a natural environment at the Reproductive Sciences Program Sheep Research Facility ͑Ann Arbor, MI; 42 deg 18 min north latitude͒. Two days before testing, sheep were isolated and solid food was withheld. Just prior to their test session, sheep were brought to the test location where they were injected with ketamine hydrochloride ͑4-6 mg/ kg, iv͒ and diazepam ͑0.2-0.3 mg/ kg, iv͒, intubated, and placed on a thick foam pad on a surgical table. In Fall 2006, the sheep were placed supine on the table, and in Spring 2007, they lay on their right side. For both body positions, the left ear was oriented upward. The sheep's hindquarters were elevated several inches above its head to permit drainage from the rumen, throat, and mouth. Anesthesia was maintained with a mixture of halothane gas ͑approximately 1.5%͒ in nitrous oxide ͑1 / 3͒ and oxygen ͑2 / 3͒. Otoscopy was performed, the ear canals were cleaned as necessary ͑female ear canals required less cleaning than male's͒, and a probe tip was fitted into the left ear canal. For most animals, CEOAEs and DPOAEs were collected for the left ear only.
Two Etymotic ER-2 earphones ͑Etymotic Research, Elk Grove Village, IL͒ were used to present the two primary tones needed to evoke DPOAEs, and an Etymotic ER-10Bϩ microphone was used to record the sounds from the ear canal. Typically, rubber tips originally made for otoadmittance measurements were fitted over the end of the Etymotic probe tip, but for some especially large canals, special oversized foam plugs were fitted. The probe tip was traversed by two silicon sound-delivery tubes attached to the two earphones.
Stimuli were presented and responses collected using a Macintosh laptop computer ͑Power Macintosh G3, Apple Computer, Cupertino, CA͒ connected to a data-acquisition board ͑PCI-4451, National Instruments, Austin, TX͒ that was installed in a PCI-bus-extension chassis. All stimulus presentation and data collection was accomplished using customwritten LabView software ͑National Instruments, Austin, TX͒ running on the Macintosh laptop computer. A 50-kHz sampling rate ͑16-bit precision͒ was used both for digitizing the output from the microphone system and for generating the acoustic stimuli for presentation to the ear.
Typically, the DPOAE data were collected after CEOAE data had been collected. ͑For the first few sheep tested, CEOAEs were collected only with clicks at 75 dB peakequivalent sound-pressure level ͑peSPL͒, but for the majority of animals, CEOAEs were collected with both 75-and 81-dB clicks.͒ The procedure used to measure DPOAEs was a variant of CUBDIS ͑Allen, 1990͒; details of our version have been published ͑McFadden et al., 2006a͒. Briefly, two primary tones, f 1 and f 2 ͑f 2 Ͼ f 1 ͒, of equal sound-pressure level and having a frequency ratio ͑f 2 / f 1 ͒ of approximately 1.21, were presented for 4-s intervals while the frequency region centered on 2f 1 − f 2 was monitored.
The levels of the primaries initially were set to 50 dB each, and if a distortion product of −10 dB SPL or stronger was measured, then the levels of the primaries were diminished by 7 dB. If the distortion product still was at least −10 dB SPL, then the levels of the primaries were reduced again by 7 dB, and so on until the distortion product was less than −10 dB SPL. Then the levels of the primaries were set to 57 dB each, the distortion product was measured, and the primary levels were increased again until either the levels reached 71 dB each or the magnitude of the distortion product increased less than 3 dB for a 7-dB increase in the primaries. The result was a gain function relating the strength of the distortion product to the level of the primaries. After that sequence was complete, the frequencies of the two primaries were increased by approximately 100 Hz, their levels both were set to 50 dB, and the sequence just described was implemented again until another gain function was obtained. This procedure was repeated until six gain functions were obtained in a localized frequency region. A similar set of six gain functions was obtained in two other frequency regions; the three frequency regions for the DPOAEs themselves were approximately 2.0-2.5, 3.3-3.8, and 5.0-5.5 kHz. ͑These correspond to frequency ranges of about 3. 06-3.83, 5.05-5.82, and 7.66-8.42 kHz, respectively, for the f 2 tone.͒ The data for the three frequency regions were collected in a different order for each subject. The six gain functions within each frequency region were combined to produce one composite gain function for each frequency region for each ear ͑for the details see McFadden et al. 2006a͒ , and those composite gain functions were used to obtain estimates of the strength of the primary tones necessary to generate a distortion product of 0 dB SPL. Thus, in this context, the presence of a strong distortion product is revealed by small values of the estimated primary levels. In order to avoid confusion, we generally will discuss the results in terms of the relative strength of the DPOAEs themselves, not the levels of the primaries necessary to elicit a constant DPOAE strength.
The Ns for all of the groups studied were small even before the loss of the no-DPOAE animals. The usefulness of statistical tests for placing individual comparisons in perspective therefore was diminished. As a supplement to statistical tests, we provide effect sizes, which are calculated as the difference between the means of the two groups of interest divided by the square root of the weighted mean of the two variances for those two groups. According to Cohen ͑1992͒, effect sizes of 0.2, 0.5, and 0.8 correspond to small, medium, and large effects, respectively. All t-tests conducted were equal variance, unmatched, and two tailed.
III. RESULTS
The absence of measurable DPOAEs in a large fraction of both the male and female sheep means that our ability to reach confident conclusions about treatment effects was reduced. Accordingly, the primary emphasis here is on the characteristics of the sheep having no measurable DPOAEs and on possible procedural details that might have contributed to this anomalous outcome. Analyses for sex differences and treatment effects also are reported, but considerable caution is necessary when interpreting those outcomes because of the possibility of a selection bias existing in the attrition process. For background, we note that the CEOAEs of sheep having, and not having, DPOAEs were not noticeably different, so those two groups were pooled for the presentation of those data ͑McFadden et al., 2008b͒.
A. Characteristics of sheep not having DPOAEs
The absence of DPOAEs in the presence of apparently typical CEOAEs seemingly had no relationship to the various treatment groups in either sex. In Table I are shown both the number of sheep having DPOAEs ͑the numerators͒ and the total number of sheep from which OAE measures were obtained in each of the various treatment categories ͑the denominators͒. Also, one additional untreated/intact female had extremely weak DPOAEs in all three frequency regions, three of the four untreated/GDX females had no measurable DPOAEs in two frequency regions and very weak DPOAEs in the 3.5-kHz region, and two other males had no measurable DPOAEs in one of the three frequency regions. Thus, slightly more than one-third of the animals had no, or weak, DPOAEs across both the sexes and the treatment groups. As noted, this loss of animals substantially reduced our ability to make trustworthy statistical comparisons between groups, and consequently we emphasize effect sizes.
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B. CEOAE strength in sheep not having DPOAEs
The CEOAEs exhibited by the sheep having no DPOAEs varied widely in strength. As a way of demonstrating that fact, special scattergram plots were prepared. Figures  1 and 2 show the scattergrams for females and males, respectively. For these figures, each sheep contributed three DPOAE values ͑one for each frequency region͒, all plotted at a single CEOAE value. In both figures, ordinate values greater than 90 dB are dummy values assigned when a sheep lacked DPOAEs in one or more of the three frequency regions measured. ͑Three additional female sheep and two additional male sheep had usable DPOAE data, but they do not TABLE I. Number of female and male sheep exhibiting DPOAEs in at least one frequency region ͑numerator͒ and number of sheep measured in that category ͑denominator͒. For this study, the untreated and untreated/GDX sheep were combined within sex to create the two control groups, and the non-obese and obese females were combined to create a single female prenatal-testosterone group. GDX represents gonadectomized; DHT represents dihydrotestosterone; untreated males were vasectomized ͑VX͒. For the females ͑Fig. 1͒, there was a seemingly paradoxical tendency for the absence of DPOAEs to be associated with relatively strong CEOAEs and for strong DPOAEs to be associated with relatively weak CEOAEs. For the males ͑Fig. 2͒, however, the absence of DPOAEs occurred over the full range of CEOAE strength. An interesting fact is that the two males having the strongest and weakest CEOAEs both lacked measurable DPOAEs. The correlations between the CEOAE values and the primary levels necessary for a DPOAE of 0 dB at 3.5 kHz were 0.58 and 0.43 for the females and males, respectively ͑with the dummy values omitted͒. These both actually are "negative relationships" in that strong CEOAEs tended to be associated with weaker DPOAEs.
C. Possible technical problems
Because an absence of DPOAEs in ears having CEOAEs is not a common outcome in human ears, some assurances are needed that a technical problem or procedural error was not to blame. The shortage of time available for additional study of these ears necessarily limits our knowledge, but this is what can be said.
͑1͒
The dissociation was unlikely to be attributable simply to the order of collection of the data. Although CEOAE data typically were collected prior to the DPOAE data, dissociations also were seen when the order was reversed.
͑2͒
The dissociation was unlikely to be attributable to the choice of stimulus parameters used for DPOAE collection. The f 2 / f 1 ratio used ͑approximately 1.21͒ is in the range of optimal ratios reported for an array of different mammalian species ͑reviewed by Valero et al., 2008͒ , and small variations from the optimal ratio for an individual animal have never been shown to produce large changes in DPOAE magnitude. ͑3͒ The dissociation could not be attributed to one of the earphones failing to present its primary tone because those tones were calibrated in the ear canal using the Etymotic microphone, and their actual levels in the canal at the time of testing were recorded along with the level of the DPOAE. ͑4͒ The dissociation seems unlikely to be attributable to the anesthetic used because the CEOAEs obtained from the ears without DPOAEs covered a wide range ͑see Figs. 1 and 2͒. Also, in some animals, DPOAEs were absent even though the attempt to measure DPOAEs began immediately after starting the anesthetic, and in no individual animal was there evidence of DPOAEs getting weaker with time spent under anesthetic. Within a single approximately 60-min session, some sheep first showed strong CEOAEs at both click levels, then no DPOAEs, and then strong CEOAEs again when retested. For one male sheep having strong DPOAEs, especially in the 3.5-kHz region, the halothane dose was increased at the end of the test session with no evident effect on DPOAE strength. Many of the sheep having no DPOAEs had never before received gas anesthetic; some others had received halothane once, months before, for about 20 min. Guven et al. ͑2006͒ concluded that halothane has no effect on human CEOAEs ͑compare Kettembeil et al., 1995 , for birds͒, and ketamine long has been used when recording OAEs in nonhumans ͑e.g., Martin et al., 1999; Torre and Fowler, 2000; Hatzopoulos et al., 2002͒. Bergevin et al. ͑2008͒ also concluded that anesthesia often has minimal effects on OAEs. ͑5͒ The dissociation was unlikely to be attributable to occlusions in the ear canal or to a poorly located probe tip because we continued to observe the dissociation in several sheep even after removing and repositioning the probe tip in the ear canal. Also, the majority of the sheep without DPOAEs exhibited no DPOAEs in any of the three frequency regions tested; generally it was not localized to just one frequency region as might be expected if the probe tip had shifted. Finally, is not clear how occlusions or a misplaced probe tip could affect only the DPOAEs. ͑6͒ The dissociation was unlikely to be attributable to a gradual build-up of a pressure differential in the middle and external ears ͑Kettembeil et al., 1995; Zheng et al., 1997͒. In several sheep, after the probe tip had been securely sealed into the ear-canal for many minutes, the silicone tube connecting one ER-2 earphone to the earcanal space was pulled free on its proximal end, allowing the air pressure on the distal side of the probe tip to become equal to that in the test room, yet the OAEs measured afterward were the same as before. This dem- cooler in November and December than in May, yet we observed no seasonal effect on DPOAE absence. Animals with no DPOAEs were chronologically interleaved with those having DPOAEs, even though all animals were coming from the same outside temperature into the same indoor temperature. Also, there was no evidence of changes in DPOAE strength with time since leaving the outdoors and coming indoors. Finally, we find it unlikely that temperature could affect only DPOAEs, leaving CEOAEs normal. ͑9͒ An idea that we were not able to test was that perhaps the animals exhibiting no DPOAEs had extremely strong middle-ear muscles that were well activated by the longduration primary tones used to elicit DPOAEs but were not activated by the brief click stimuli used to elicit CEOAEs. A strong acoustic reflex would impair transmission into and out of the cochlea and could possibly lead to the appearance of an absence of DPOAEs. Besides being rather far-fetched, this idea is offset by the fact that our maximum-length-sequence ͑MLS͒ click procedure involved relatively short interclick intervals ͑the shortest being about 10 ms͒. 
D. Sex differences in DPOAEs
Although OAEs are routinely reported to exhibit sex and ear differences ͑e.g., Bilger et al., 1990; Talmadge et al., 1993; McFadden, 1993; McFadden et al., 1996; Pasanen, 1998, 1999; McFadden and Shubel, 2003͒ , those differences typically are smaller for DPOAEs than for CEOAEs or SOAEs ͑for a review, see McFadden et al., 2008a͒ . Because only one ear was measured for most of the sheep, ear differences cannot be reported here. In order to calculate sex differences for the DPOAE data, the subjects were pooled in the same way as for the CEOAE calculations ͑McFadden et al., 2008b͒. Namely, the untreated/intact females were pooled with the untreated/GDX females to form a female control group, and the untreated/VX males were pooled with the untreated/GDX males to form a male control group.
As can be seen in Fig. 3 , control females required stronger primary tones than control males to produce the same DPOAE magnitude. That is, the females had weaker DPOAEs than the males and that was true in each of the three frequency regions tested for DPOAEs. This is opposite to the direction of effect previously reported for DPOAEs in humans ͑McFadden et al., 2008a͒ and other species ͑e.g., McFadden et al., 2006a; Valero et al., 2008͒ . This sex difference also differs in direction from the sex difference exhibited by these same sheep for CEOAEs ͑McFadden et al., 2008b͒. The effect sizes for the sex differences in the DPOAEs are shown separately for each frequency region in Table II . All three effect sizes were moderate to large in size ͑Cohen, 1992͒, but none of the three comparisons was statistically significant for these small samples.
E. Treatment effects
In order to assess the effects of prenatal hormone treatment on DPOAEs in females, the obese/testosterone-treated females were pooled with the nonobese/testosterone-treated females and that group was compared with the female control group described above. These two groups of testosterone-treated females were pooled in this same way when analyzing their CEOAE data ͑McFadden et al., 2008b͒. Figure 3 reveals that the females treated with testosterone prenatally required substantially weaker primary tones than the control females to produce a DPOAE of the same magnitude; that is, the testosterone-treated females had stronger DPOAEs than the control females. Again, this is the opposite direction of effect from that shown by these same animals for CEOAEs ͑McFadden et al., 2008b͒. Note, however, that the DPOAE data for these testosterone-treated females were shifted in the male direction just as their CEOAE data were ͑McFadden et al., 2008b͒. That is, the testosterone-treated females did exhibit masculinized DPOAEs, in accord with expectations based on their treatment. Table II reveals that the effect sizes for these comparisons were large for all three frequency regions tested, and the comparison at 3.5 kHz achieved statistical significance, unpaired t͑21͒ = 3.51, p = 0.002, two-tailed test, equal variance. These testosteronetreated females are also masculinized in other ways. They are born with no vaginal opening, with an empty scrotal sac, and with a pseudopenis that is used for urination ͑no erections ever have been observed͒; they also exhibit various neuroendocrine and ovarian differences from untreated females ͑see Padmanabhan et al., 2006͒ as well as behavioral differences ͑Roberts et al., 2008͒. So the prenatal treatment was effective at masculinizing both the body and the cochlea.
An interesting outcome is that the two females treated with estradiol prenatally had DPOAEs that were masculinized to about the same extent as the DPOAEs of the females treated with testosterone prenatally. This may seem paradoxical, but testosterone is aromatized to estradiol in mammals, so individuals high in testosterone are likely to be high in estradiol as well. The implication is that estradiol, not androgen, may be the relevant agent for masculinizing the cochlea. However, considerable caution must accompany this implication because the N was extremely small. Figure 3 also shows the differences in DPOAE strength between the control males and those males treated with testosterone propionate or DHT prenatally. However, no effect sizes or statistical tests are reported because of the extremely small N remaining in these groups after attrition. For comparison, the CEOAEs of the testosterone-treated males were about the same as the CEOAEs of the control males, and the CEOAEs of the DHT-treated males were somewhat stronger than those of the control males, just as was true for the DPOAEs shown in Fig. 3 .
F. Slopes of the gain functions
Examination of the slopes of the lines fitted to the linear ranges of the gain functions revealed that the strength of the DPOAE grew slowest with increases in primary levels in the lowest frequency region tested and grew increasingly more rapidly for each move to a higher frequency region. This trend was evident in both sexes, with the three slopes for the control females being slightly steeper than the three corresponding slopes for the control males. Also, the slopes for the testosterone-treated females were masculinized. When the slopes were pooled for all 15 males and all 23-26 females, the sex difference disappeared, and the mean slopes were about 0.85, 0.96, and 1.16 for the 2.0-, 3.5-, and 5.0-kHz frequency regions, respectively. 
G. Relative strength of DPOAEs
One way to demonstrate differences across individuals or across species is to compare the strength of the primary tones used to evoke DPOAEs to the strength of the 2f 1 − f 2 component produced by those primary tones. That is, how many decibels weaker than the primaries was the DPOAE? For sheep, the measurable DPOAEs averaged about 45 dB ͑males͒ to 50 dB ͑females͒ weaker than the primary tones. This is very similar to what we have obtained from spotted hyenas ͑McFadden et al., 2006b͒, rhesus monkeys ͑McFad-den et al., 2006a͒, and lemurs ͑unpublished͒. The DPOAEs of marmosets were a bit weaker, averaging about 50 dB ͑fe-males͒ to 57 dB ͑males͒ weaker than the primaries ͑Valero et al., 2008͒. All of these values are considerably stronger than those for humans, which average about 60-68 dB weaker than the primary tones for both sexes ͑Harris et al., 1989; McFadden et al., 2008a͒ . Furthermore, the gain functions for DPOAEs in sheep typically asymptoted at about 25-30 dB SPL whereas the gain functions for humans we have tested with similar procedures and in comparable frequency ranges typically asymptoted at ϳ5 -15 dB SPL.
The considerable strength of the measurable DPOAEs in sheep is notable in light of both the dissociation between DPOAEs and CEOAEs seen in some animals and the fact that hearing sensitivity in sheep is about 18 dB worse than in humans over the range of DPOAEs and primary tones tested here ͑Wollack, 1963͒. For comparison, our past measurements reveal that the CEOAEs of sheep are weaker than those of rhesus monkeys, which in turn are weaker than those of humans.
IV. DISCUSSION
To our knowledge, these are the first measurements of OAEs in a ruminant species. The DPOAEs measured had some similarities with DPOAEs measured in humans and some differences. Surely the most interesting discovery was the large fraction of sheep having apparently normal CEOAEs but no, or quite weak, DPOAEs. Several possible technical problems or procedural errors that might have contributed to this marked dissociation were considered, but none seemed to be plausible explanations. Until a fully explanatory problem or error emerges, we believe that this species tentatively ought to be viewed as unusual and worthy of further study. Sheep appear to offer considerable potential for learning more about the cochlear mechanisms responsible both for DPOAEs and the other forms of OAE.
Shera and Guinan ͑1999͒ explained DPOAEs by assuming that the distortion mechanism that rides the displacement envelope in the vicinity of f2 gives rise to a wave at the 2f1− f2 frequency that travels both back to the stapes and forward to the 2f1− f2 location on the basilar membrane. The forward-propagating wave is thought to encounter one or more discontinuities along its path, leading to a reflectionbased wave also traveling backward toward the stapes. Thus, the DPOAE measured in the ear canal is a mix of two responses, one directly from the distortion mechanism and the other indirectly from the distortion mechanism. Accordingly, a simple explanation for how some sheep can have apparently normal CEOAEs ͑a reflection-based form of OAE͒ but no DPOAEs ͑a mix of two forms of OAE͒ would be that their distortion mechanism is damaged or inactive. Exactly what that would mean mechanistically or anatomically is far from clear. Because DPOAEs often were absent over a substantial range of f 2 frequencies, the implication is that the distortion mechanism had to be unable to function over a substantial segment of the basilar membrane even though the reflection mechanism and the cochlear-amplification process apparently were intact over that same segment of basilar membrane. Under this Shera and Guinan ͑1999͒ explanation, it is not clear how a localized lesion could account for the marked wideband dissociation between CEOAEs and DPOAEs in some sheep.
Although rarely stated explicitly, there appears to exist an implicit assumption among hearing scientists that each of the two mechanisms underlying the various forms of OAE is highly similar, if not identical, across all mammalian species ͑Bergevin et al., 2008͒. The results from sheep appear to contradict this assumption of a universal mammalian plan.
͑1͒ It appears to be reasonably common for individual sheep to have perfectly normal-appearing CEOAEs even though they have no measurable DPOAEs ͑see Figs. 1 and 2͒, a unique finding in mammals so far. ͑2͒ While the ͑small͒ sex difference for CEOAEs did favor the females ͑McFadden et al., 2008b͒, as in other mammals, the sex difference for DPOAEs favored the males ͑see Fig. 3 and Table II͒ . In humans ͑Bilger et al Talmadge et al., 1993; McFadden, 1993; McFadden et al., 1996; Pasanen, 1998, 1999; Shubel, 2003͒ and rhesus monkeys ͑McFadden et al., 2006a͒ , the sex difference for CEOAEs is moderate in size and also favors the females, whereas the sex difference for DPOAEs typically is smaller than for CEOAEs ͑McFadden et al., 2008a͒ but still favors the females. ͑3͒ Female sheep exposed to higher-than-normal levels of androgens during the middle part of gestational development exhibited weaker CEOAEs than untreated females, which is in accord with a considerable array of outcomes from various species and special populations of humans ͑McFadden, 2002, 2008͒. However, those same androgen-treated females exhibited DPOAEs that were stronger than those in untreated females-the opposite direction of effect for CEOAEs. What is fascinating about this outcome is that the testosterone-treated females still were exhibiting a masculinized cochlea; their DPOAEs were shifted in the male direction of stronger DPOAEs than in the females. Thus, both the CEOAEs and DPOAEs of sheep offer confirmation of the prenatalandrogen-exposure explanation ͑McFadden, 2002, 2008͒ even though their DPOAEs exhibited an anomalous sex difference. To our knowledge, the only other report of a reversal in the direction of effect for the sex difference is for both the CEOAEs and DPOAEs of spotted hyenas ͑McFadden et al., 2006b͒, where an absence of sex difference was predicted because female spotted hyenas are naturally exposed to high levels of androgens prenatally.
